Short-term detection of gastric genotoxicity using the DNA double-strand break marker γ-H2AX.

DNA double-strand break gastric cancer p21 pepsinogen stomach γ-H2AX

Journal

Journal of toxicologic pathology
ISSN: 0914-9198
Titre abrégé: J Toxicol Pathol
Pays: Japan
ID NLM: 9306408

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 22 01 2019
accepted: 13 02 2019
entrez: 17 5 2019
pubmed: 17 5 2019
medline: 17 5 2019
Statut: ppublish

Résumé

DNA damage caused by

Identifiants

pubmed: 31092975
doi: 10.1293/tox.2019-0007
pii: 2019-0007
pmc: PMC6511543
doi:

Types de publication

Journal Article

Langues

eng

Pagination

91-99

Références

Mutat Res. 2000 Apr;462(2-3):219-26
pubmed: 10767633
Carcinogenesis. 2000 Oct;21(10):1891-7
pubmed: 11023548
Jpn J Cancer Res. 2001 Feb;92(2):109-18
pubmed: 11223539
Hiroshima J Med Sci. 2001 Mar;50(1):1-7
pubmed: 11314855
Cancer Lett. 2002 May 28;179(2):121-32
pubmed: 11888666
Cancer Sci. 2003 Feb;94(2):135-41
pubmed: 12708487
Biochem Cell Biol. 2003 Jun;81(3):123-9
pubmed: 12897845
Biochem Biophys Res Commun. 2005 Oct 28;336(3):807-12
pubmed: 16153602
Cancer Lett. 2006 Aug 8;239(2):205-11
pubmed: 16168562
Carcinogenesis. 2006 Jul;27(7):1497-501
pubmed: 16571648
Curr Cancer Drug Targets. 2006 May;6(3):197-205
pubmed: 16712457
Aliment Pharmacol Ther. 2007 Jan 15;25(2):133-41
pubmed: 17229238
Genes Dev. 2007 Mar 15;21(6):644-8
pubmed: 17369397
Nat Med. 2007 Apr;13(4):470-6
pubmed: 17401375
Cytometry A. 2007 Sep;71(9):648-61
pubmed: 17622968
J Histochem Cytochem. 2008 Aug;56(8):711-21
pubmed: 18474937
Nat Rev Cancer. 2008 Dec;8(12):957-67
pubmed: 19005492
Trends Cell Biol. 2009 May;19(5):207-17
pubmed: 19342239
Int J Cancer. 2009 Oct 15;125(8):1786-95
pubmed: 19610061
Int J Cancer. 2012 Jan 15;130(2):259-66
pubmed: 21387296
J Toxicol Pathol. 2013 Jun;26(2):215-21
pubmed: 23914065
Methods Mol Biol. 2014;1105:193-202
pubmed: 24623230
Gastroenterology. 2014 Aug;147(2):407-17.e3
pubmed: 24786892
Helicobacter. 2014 Sep;19 Suppl 1:32-7
pubmed: 25167943
Arch Biochem Biophys. 2016 Mar 15;594:18-25
pubmed: 26882840
J Radiat Res. 2016 Jun;57(3):312-7
pubmed: 26951077
Trends Mol Med. 2017 Apr;23(4):310-319
pubmed: 28279624
Int J Mol Sci. 2017 Apr 28;18(5):null
pubmed: 28452953
Environ Mol Mutagen. 2017 Jun;58(5):235-263
pubmed: 28485537
Int J Mol Sci. 2017 Aug 03;18(8):null
pubmed: 28771198
Biol Res. 2017 Sep 7;50(1):27
pubmed: 28882183
Toxicology. 2018 Jul 1;404-405:68-75
pubmed: 29777724
J Toxicol Sci. 2018;43(6):359-367
pubmed: 29877212
J Toxicol Pathol. 2018 Jul;31(3):163-168
pubmed: 30093785
Front Genet. 2018 Sep 12;9:390
pubmed: 30258457
Cancer Lett. 1981 Dec;14(3):279-83
pubmed: 6800641
Mutat Res. 1993 Jun;287(2):307-19
pubmed: 7685490
Int J Radiat Biol. 1997 Mar;71(3):283-91
pubmed: 9134018
Mol Reprod Dev. 1997 Jul;47(3):240-7
pubmed: 9170103

Auteurs

Asako Okabe (A)

Department of Diagnostic Pathology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.

Yuka Kiriyama (Y)

Department of Diagnostic Pathology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.
Department of Diagnostic Pathology, Narita Memorial Hospital, 134 Haneihonmachi, Toyohashi, Aichi 441-8029, Japan.

Shugo Suzuki (S)

Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan.

Kouhei Sakurai (K)

Department of Diagnostic Pathology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.

Atsushi Teramoto (A)

Faculty of Radiological Technology, Fujita Health University Graduate School of Health Sciences, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.

Hiroyuki Kato (H)

Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan.

Aya Naiki-Ito (A)

Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan.

Sayumi Tahara (S)

Department of Diagnostic Pathology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.

Satoru Takahashi (S)

Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan.

Makoto Kuroda (M)

Department of Diagnostic Pathology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.

Atsushi Sugioka (A)

Department of Surgery, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.

Tetsuya Tsukamoto (T)

Department of Diagnostic Pathology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.

Classifications MeSH